AnaptysBio (NASDAQ:ANAB) Price Target Raised to $51.00
AnaptysBio (NASDAQ:ANAB – Free Report) had its price target boosted by Wells Fargo & Company from $40.00 to $51.00 in a report issued on Thursday,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the biotechnology company’s stock. A number of other equities research analysts also recently issued reports on ANAB. Wedbush restated […]
AnaptysBio (NASDAQ:ANAB – Free Report) had its price target boosted by Wells Fargo & Company from $40.00 to $51.00 in a report issued on Thursday,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the biotechnology company’s stock. A number of other equities research analysts also recently issued reports on ANAB. Wedbush restated […]
